FeedsFarm.com > Trastuzumab May Prompt Change in Practice Recommendations for HER2-Positive Breast Cancer

Source:

Medscape Pharmacist Headlines

Language:

English

Tag/Category:

hematology-oncology

Domain:

www.medscape.com

More feeds from medscape.com:

• Medscape Business of Medicine Headlines
• Medscape Diabetes Headlines
• Medscape Internal Medicine Headlines
• Medscape Nephrology Headlines
• Medscape Neurology Headlines
• Medscape Pathology Headlines
• Medscape PublicHealth Headlines
• Medscape Technology and Medicine Headlines
• Medscape Transplantation Headlines
• Medscape Womens Health Headlines

Search medscape.com:

Trastuzumab May Prompt Change in Practice Recommendations for HER2-Positive Breast Cancer

20th Oct 2005, 22:35 GMT

Two studies suggested improved outcomes from adding trastuzumab after adjuvant chemotherapy in women with surgically removed HER2-positive breast cancer. (CME) Medscape Medical News Laurie Barclay,Desiree Lie,Gary Vogin

Latest news from Medscape Pharmacist Headlines:

• Selective TZD Use Won't Exacerbate HF Symptoms in Diabetics With Heart Failure, Says Analysis
• Treating the Negative Symptoms of Schizophrenia: An Expert Interview With Joseph Coyle, MD
• Highlights of the 2006 Annual Convention of the National Community Pharmacists Association